Mainz, Germany, January 12, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will provide a strategic business update and outline the Company’s focus areas for 2026, including an ...
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
KTSM El Paso on MSN
County to create 'best practices' for data centers
The El Paso County Commissioners Court voted Monday, Jan. 5, to direct County staff to begin developing a “best practices” ...
The cautious start to indices follows a fifth straight session of losses on Friday, which pushed the Nifty closer to its ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.
Tesla pivots FSD to a subscription-only form, removing the $8,000 upfront fee to drive adoption and recurring high-margin ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...
Detailed price information for Jasper Therapeutics Inc. (JSPR-Q) from The Globe and Mail including charting and trades.
Tesco’s failure to meet lofty City expectations and a warning by the owner of Primark today fuelled retail sector selling ...
NVIDIA's consumer graphics presentation at CES 2026 was more interesting than many, although we'll spoil the surprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback